Programme

Programme

Programme

ECNM 2025 Annual Meeting - Programme

ECNM 2025 Annual Meeting - Programme

Day 1, Thursday 18

Day 1, Thursday 18

Day 1, Thursday 18

September 2025

September 2025

September 2025

12:00

Registration opens

12:00

Registration opens

12:00

Registration opens

12:30–12:40

Welcome

Dr Deepti Radia & Dr Clive Grattan

12:30–12:40

Welcome

Dr Deepti Radia & Dr Clive Grattan

12:30–12:40

Welcome

Dr Deepti Radia & Dr Clive Grattan

12:40–13:00

Welcome and introduction

• Status of the ECNM • Presentation of Researcher of the Year award

Professor Peter Valent & Professor Massimo Triggiani

12:40–13:00

Welcome and introduction

• Status of the ECNM • Presentation of Researcher of the Year award

Professor Peter Valent & Professor Massimo Triggiani

12:40–13:00

Welcome and introduction

• Status of the ECNM • Presentation of Researcher of the Year award

Professor Peter Valent & Professor Massimo Triggiani

13:00–13:40

Utility and application of KIT mutations and other molecular markers in mast cell neoplasms

Professor Michel Arock

13:00–13:40

Utility and application of KIT mutations and other molecular markers in mast cell neoplasms

Professor Michel Arock

13:00–13:40

Utility and application of KIT mutations and other molecular markers in mast cell neoplasms

Professor Michel Arock

13:40–14:00

Afternoon coffee break

13:40–14:00

Afternoon coffee break

13:40–14:00

Afternoon coffee break

14:00–15:00

SESSION 1: Updates in pathology and classification

• Harmonisation of the EU/US, ICC and WHO classificationof mastocytosis • Application of ICC and WHO criteria by the pathologist • Histopathological and phenotypic changes of mast cellsduring TKI therapy • Rare cases and histopathological patterns in SM-AHN

Chaired by Professor Wolfgang R Sperr & Professor Karl Sotlar Professor Peter Valent Professor Karl Sotlar Professor Tracy George Professor Hans Peter Horny

14:00–15:00

SESSION 1: Updates in pathology and classification

• Harmonisation of the EU/US, ICC and WHO classificationof mastocytosis • Application of ICC and WHO criteria by the pathologist • Histopathological and phenotypic changes of mast cellsduring TKI therapy • Rare cases and histopathological patterns in SM-AHN

Chaired by Professor Wolfgang R Sperr & Professor Karl Sotlar Professor Peter Valent Professor Karl Sotlar Professor Tracy George Professor Hans Peter Horny

14:00–15:00

SESSION 1: Updates in pathology and classification

• Harmonisation of the EU/US, ICC and WHO classificationof mastocytosis • Application of ICC and WHO criteria by the pathologist • Histopathological and phenotypic changes of mast cellsduring TKI therapy • Rare cases and histopathological patterns in SM-AHN

Chaired by Professor Wolfgang R Sperr & Professor Karl Sotlar Professor Peter Valent Professor Karl Sotlar Professor Tracy George Professor Hans Peter Horny

15:00–15:30

Afternoon coffee break

15:00–15:30

Afternoon coffee break

15:00–15:30

Afternoon coffee break

15:30–16:45

SESSION 2: Updates in paediatric and adult dermatological presentations of mast cell disease

• Diagnosis and management of skin problems in paediatricmastocytosis • Quantification of skin disease in CM and SM during therapy • Therapy of cutaneous disease in pediatric CM • Phototherapy and photochemotherapy in CM and SM • Challenges and potential shortfalls in current classificationof cutaneous mastocytosis

Chaired by Professor Magdalena Lange & Professor Vito Sabato Dr Melody Carter Professor Karin Hartmann Professor Magdalena Lange Dr Valeria Brazzelli Professor Iván Álvarez-Twose

15:30–16:45

SESSION 2: Updates in paediatric and adult dermatological presentations of mast cell disease

• Diagnosis and management of skin problems in paediatricmastocytosis • Quantification of skin disease in CM and SM during therapy • Therapy of cutaneous disease in pediatric CM • Phototherapy and photochemotherapy in CM and SM • Challenges and potential shortfalls in current classificationof cutaneous mastocytosis

Chaired by Professor Magdalena Lange & Professor Vito Sabato Dr Melody Carter Professor Karin Hartmann Professor Magdalena Lange Dr Valeria Brazzelli Professor Iván Álvarez-Twose

15:30–16:45

SESSION 2: Updates in paediatric and adult dermatological presentations of mast cell disease

• Diagnosis and management of skin problems in paediatricmastocytosis • Quantification of skin disease in CM and SM during therapy • Therapy of cutaneous disease in pediatric CM • Phototherapy and photochemotherapy in CM and SM • Challenges and potential shortfalls in current classificationof cutaneous mastocytosis

Chaired by Professor Magdalena Lange & Professor Vito Sabato Dr Melody Carter Professor Karin Hartmann Professor Magdalena Lange Dr Valeria Brazzelli Professor Iván Álvarez-Twose

16:45–17:15

Afternoon coffee break

16:45–17:15

Afternoon coffee break

16:45–17:15

Afternoon coffee break

17:15–18:15

SESSION 3: Comorbidities in mastocytosis

• Bone health and disease management in patients with SM • Drug reactions and food intolerance in mastocytosis • Causes of death in patients with mastocytosis: Impactof comorbidities • IgE-dependent allergies in mastocytosis

Chaired by Professor Knut Brockow & Professor Massimo Triggiani Professor Massimo Triggiani Professor Mariana Castells Dr Axel Rüfer Professor Hanneke Oude Elberink

17:15–18:15

SESSION 3: Comorbidities in mastocytosis

• Bone health and disease management in patients with SM • Drug reactions and food intolerance in mastocytosis • Causes of death in patients with mastocytosis: Impactof comorbidities • IgE-dependent allergies in mastocytosis

Chaired by Professor Knut Brockow & Professor Massimo Triggiani Professor Massimo Triggiani Professor Mariana Castells Dr Axel Rüfer Professor Hanneke Oude Elberink

17:15–18:15

SESSION 3: Comorbidities in mastocytosis

• Bone health and disease management in patients with SM • Drug reactions and food intolerance in mastocytosis • Causes of death in patients with mastocytosis: Impactof comorbidities • IgE-dependent allergies in mastocytosis

Chaired by Professor Knut Brockow & Professor Massimo Triggiani Professor Massimo Triggiani Professor Mariana Castells Dr Axel Rüfer Professor Hanneke Oude Elberink

18:15–18:55

Keynote lecture 1:

Mast cells and basophils in allergo-oncology: Bridging allergy to cancer

Introduced by Dr Clive Grattan Professor Sophia Karagiannis

18:15–18:55

Keynote lecture 1:

Mast cells and basophils in allergo-oncology: Bridging allergy to cancer

Introduced by Dr Clive Grattan Professor Sophia Karagiannis

18:15–18:55

Keynote lecture 1:

Mast cells and basophils in allergo-oncology: Bridging allergy to cancer

Introduced by Dr Clive Grattan Professor Sophia Karagiannis

18:55–19:00

Summary of Day 1 and announcements

18:55–19:00

Summary of Day 1 and announcements

18:55–19:00

Summary of Day 1 and announcements

19:30–20:30

19:30–20:30

19:30–20:30

Networking reception

Networking reception

Networking reception

Join fellow attendees, faculty, and colleagues for an
evening of informal networking, accompanied by drinks and light refreshments, in the elegant
Riverview Lounge overlooking the River Thames.
This reception offers a valuable opportunity to continue discussions from the day in a relaxed setting
and to connect with peers from across the field.

Riverview Lounge, 12th Floor
Park Plaza London Riverbank Hotel, London

Kindly register for this reception
by 31 August via the following link: www.surveymonkey.com/r/XPPX26T

Join fellow attendees, faculty, and colleagues for an
evening of informal networking, accompanied by drinks and light refreshments, in the elegant
Riverview Lounge overlooking the River Thames.
This reception offers a valuable opportunity to continue discussions from the day in a relaxed setting
and to connect with peers from across the field.

Riverview Lounge, 12th Floor
Park Plaza London Riverbank Hotel, London

Kindly register for this reception
by 31 August via the following link: www.surveymonkey.com/r/XPPX26T

Join fellow attendees, faculty, and colleagues for an
evening of informal networking, accompanied by drinks and light refreshments, in the elegant
Riverview Lounge overlooking the River Thames.
This reception offers a valuable opportunity to continue discussions from the day in a relaxed setting
and to connect with peers from across the field.

Riverview Lounge, 12th Floor
Park Plaza London Riverbank Hotel, London

Kindly register for this reception
by 31 August via the following link: www.surveymonkey.com/r/XPPX26T

Day 2, Friday 19

Day 2, Friday 19

Day 2, Friday 19

September 2025

September 2025

September 2025

08:30

Welcome and registration

08:30

Welcome and registration

08:30

Welcome and registration

09:00–10:00

SESSION 4: ECNM Registry projects – part 1

• Overview of ECNM registry projects • Highlights in W1 through W8 projects • PR1: Analysis of various age groups • PR14: Body mass index in mastocytosis • PR18: Pure CM in adults

Chaired by Professor Wolfgang R Sperr & Professor Michel Arock Professor Wolfgang R. Sperr Professor Peter Valent Professor Karin Hartmann Professor Marek Niedoszytko Professor Knut Brockow

09:00–10:00

SESSION 4: ECNM Registry projects – part 1

• Overview of ECNM registry projects • Highlights in W1 through W8 projects • PR1: Analysis of various age groups • PR14: Body mass index in mastocytosis • PR18: Pure CM in adults

Chaired by Professor Wolfgang R Sperr & Professor Michel Arock Professor Wolfgang R. Sperr Professor Peter Valent Professor Karin Hartmann Professor Marek Niedoszytko Professor Knut Brockow

09:00–10:00

SESSION 4: ECNM Registry projects – part 1

• Overview of ECNM registry projects • Highlights in W1 through W8 projects • PR1: Analysis of various age groups • PR14: Body mass index in mastocytosis • PR18: Pure CM in adults

Chaired by Professor Wolfgang R Sperr & Professor Michel Arock Professor Wolfgang R. Sperr Professor Peter Valent Professor Karin Hartmann Professor Marek Niedoszytko Professor Knut Brockow

10:00–10:20

Morning coffee break

10:00–10:20

Morning coffee break

10:00–10:20

Morning coffee break

10:20–11:00

SESSION 4: ECNM Registry projects – part 2

• PR19: AHN: Frequency of subtypes and prognosis • PR42: Clinical impact of KITD816V VAF in SM • PR45: Causes of death in non-advanced SM • Overview of new projects and EU grant application

Chaired by Professor Wolfgang R Sperr & Professor Michel Arock Professor Olivier Hermine Professor Frank Siebenhaar Dr Axel Rüfer & Dr Theo Gülen Professor Peter Valent

10:20–11:00

SESSION 4: ECNM Registry projects – part 2

• PR19: AHN: Frequency of subtypes and prognosis • PR42: Clinical impact of KITD816V VAF in SM • PR45: Causes of death in non-advanced SM • Overview of new projects and EU grant application

Chaired by Professor Wolfgang R Sperr & Professor Michel Arock Professor Olivier Hermine Professor Frank Siebenhaar Dr Axel Rüfer & Dr Theo Gülen Professor Peter Valent

10:20–11:00

SESSION 4: ECNM Registry projects – part 2

• PR19: AHN: Frequency of subtypes and prognosis • PR42: Clinical impact of KITD816V VAF in SM • PR45: Causes of death in non-advanced SM • Overview of new projects and EU grant application

Chaired by Professor Wolfgang R Sperr & Professor Michel Arock Professor Olivier Hermine Professor Frank Siebenhaar Dr Axel Rüfer & Dr Theo Gülen Professor Peter Valent

11:00–11:15

Morning coffee break

11:00–11:15

Morning coffee break

11:00–11:15

Morning coffee break

11:15–12:00

SESSION SATELLITE MEETING – CLINICAL SCENARIOS

11:15–12:00

SESSION SATELLITE MEETING – CLINICAL SCENARIOS

11:15–12:00

SESSION SATELLITE MEETING – CLINICAL SCENARIOS

12:50–13:00

Group photo

12:50–13:00

Group photo

12:50–13:00

Group photo

13:00–13:45

Keynote lecture 2:

Molecular studies in mastocytosis and AHN, and use of AI tools

Introduced by Professor Peter Valent Dr Gregor Hörmann

13:00–13:45

Keynote lecture 2:

Molecular studies in mastocytosis and AHN, and use of AI tools

Introduced by Professor Peter Valent Dr Gregor Hörmann

13:00–13:45

Keynote lecture 2:

Molecular studies in mastocytosis and AHN, and use of AI tools

Introduced by Professor Peter Valent Dr Gregor Hörmann

13:45–15:00

SESSION 5: Diagnostic challenges in mastocytosis

• Lab features and flow cytometry correlates with clinicalphenotypes • I think I have the mast cell • HαT and implications in clinical practice • Early phases and pre-phases of mast cell neoplasms • Classification of pre-SM conditions and developmentof prevention strategies

Chaired by Professor Iván Álvarez-Twose & Professor Karin Hartmann Professor Alberto Orfao Dr Clive Grattan Professor Jonathan Lyons Professor Olivier Hermine Professor Peter Valent

13:45–15:00

SESSION 5: Diagnostic challenges in mastocytosis

• Lab features and flow cytometry correlates with clinicalphenotypes • I think I have the mast cell • HαT and implications in clinical practice • Early phases and pre-phases of mast cell neoplasms • Classification of pre-SM conditions and developmentof prevention strategies

Chaired by Professor Iván Álvarez-Twose & Professor Karin Hartmann Professor Alberto Orfao Dr Clive Grattan Professor Jonathan Lyons Professor Olivier Hermine Professor Peter Valent

13:45–15:00

SESSION 5: Diagnostic challenges in mastocytosis

• Lab features and flow cytometry correlates with clinicalphenotypes • I think I have the mast cell • HαT and implications in clinical practice • Early phases and pre-phases of mast cell neoplasms • Classification of pre-SM conditions and developmentof prevention strategies

Chaired by Professor Iván Álvarez-Twose & Professor Karin Hartmann Professor Alberto Orfao Dr Clive Grattan Professor Jonathan Lyons Professor Olivier Hermine Professor Peter Valent

15:00–15:25

Afternoon coffee break

15:00–15:25

Afternoon coffee break

15:00–15:25

Afternoon coffee break

15:25–16:40

SESSION 6: Anaphylaxis and mast cell activation syndrome

• Why we have mast cells: The venom interception theory • How to manage false-positive MCAS and its mimickers • Diagnosis and management of MCAS • Immunotherapy in mastocytosis • Long- or short-term Hymenoptera venom immunotherapyin mastocytosis?

Chaired by Professor Jens Peter Panse & Professor Hanneke Oude Elberink Professor Stephen Galli Dr Theo Gulen Professor Cem Akin Professor Marek Niedoszytko Professor Patrizia Bonadonna

15:25–16:40

SESSION 6: Anaphylaxis and mast cell activation syndrome

• Why we have mast cells: The venom interception theory • How to manage false-positive MCAS and its mimickers • Diagnosis and management of MCAS • Immunotherapy in mastocytosis • Long- or short-term Hymenoptera venom immunotherapyin mastocytosis?

Chaired by Professor Jens Peter Panse & Professor Hanneke Oude Elberink Professor Stephen Galli Dr Theo Gulen Professor Cem Akin Professor Marek Niedoszytko Professor Patrizia Bonadonna

15:25–16:40

SESSION 6: Anaphylaxis and mast cell activation syndrome

• Why we have mast cells: The venom interception theory • How to manage false-positive MCAS and its mimickers • Diagnosis and management of MCAS • Immunotherapy in mastocytosis • Long- or short-term Hymenoptera venom immunotherapyin mastocytosis?

Chaired by Professor Jens Peter Panse & Professor Hanneke Oude Elberink Professor Stephen Galli Dr Theo Gulen Professor Cem Akin Professor Marek Niedoszytko Professor Patrizia Bonadonna

16:40–17:10

Afternoon coffee break

16:40–17:10

Afternoon coffee break

16:40–17:10

Afternoon coffee break

17:10–18:25

SESSION 7: Translational and real-world research in mastocytosis

• Which biomarkers are useful in mast cell activation? • Detection of KIT variants in blood and skin of patients with mastocytosis • Tryptase: From bench to clinical use in applied haematology • Biology of tryptase and application in practice • Tryptase as a screening parameter in paediatric mastocytosis

Chaired by Dr Sigurd Broesby-Olsen & Professor Marek Niedoszytko Professor Gunnar Nilsson Professor Sigurd Broesby-Olsen Professor Wolfgang R. Sperr Professor Lawrence B. Schwartz Professor Knut Brockow

17:10–18:25

SESSION 7: Translational and real-world research in mastocytosis

• Which biomarkers are useful in mast cell activation? • Detection of KIT variants in blood and skin of patients with mastocytosis • Tryptase: From bench to clinical use in applied haematology • Biology of tryptase and application in practice • Tryptase as a screening parameter in paediatric mastocytosis

Chaired by Dr Sigurd Broesby-Olsen & Professor Marek Niedoszytko Professor Gunnar Nilsson Professor Sigurd Broesby-Olsen Professor Wolfgang R. Sperr Professor Lawrence B. Schwartz Professor Knut Brockow

17:10–18:25

SESSION 7: Translational and real-world research in mastocytosis

• Which biomarkers are useful in mast cell activation? • Detection of KIT variants in blood and skin of patients with mastocytosis • Tryptase: From bench to clinical use in applied haematology • Biology of tryptase and application in practice • Tryptase as a screening parameter in paediatric mastocytosis

Chaired by Dr Sigurd Broesby-Olsen & Professor Marek Niedoszytko Professor Gunnar Nilsson Professor Sigurd Broesby-Olsen Professor Wolfgang R. Sperr Professor Lawrence B. Schwartz Professor Knut Brockow

18:25–18:30

Summary of Day 2 and announcements

18:25–18:30

Summary of Day 2 and announcements

18:25–18:30

Summary of Day 2 and announcements

19:00–22:00

19:00–22:00

19:00–22:00

Networking dinner

Networking dinner

Networking dinner

Join colleagues, faculty, and peers for a formal seated dinner in a distinguished setting, offering the perfect opportunity to unwind after a full day of engaging scientific discussions.

Enjoy an elegant evening of fine dining and conversation in the company of leading experts from across the field.

Dinner at Merchant Taylors’ Hall, City of London

Kindly register for this dinner by 31 August via the following link: www.surveymonkey.com/r/3YZDHTL

Join colleagues, faculty, and peers for a formal seated dinner in a distinguished setting, offering the perfect opportunity to unwind after a full day of engaging scientific discussions.

Enjoy an elegant evening of fine dining and conversation in the company of leading experts from across the field.

Dinner at Merchant Taylors’ Hall, City of London

Kindly register for this dinner by 31 August via the following link: www.surveymonkey.com/r/3YZDHTL

Join colleagues, faculty, and peers for a formal seated dinner in a distinguished setting, offering the perfect opportunity to unwind after a full day of engaging scientific discussions.

Enjoy an elegant evening of fine dining and conversation in the company of leading experts from across the field.

Dinner at Merchant Taylors’ Hall, City of London

Kindly register for this dinner by 31 August via the following link: www.surveymonkey.com/r/3YZDHTL

Day 3, Saturday 20

Day 3, Saturday 20

Day 3, Saturday 20

September 2025

September 2025

September 2025

08:00

Welcome and registration

08:00

Welcome and registration

08:00

Welcome and registration

08:30–09:30

SESSION 8: Prognostication and efficacy of novel TKIs in SM

• Development of MARS-R • Efficacy of recently approved and novel TKIs in SM clinicalpractice • Real-world data of avapritinib-treated patients with ISM • Diagnosis, prognostication and therapy of WDSM

Chaired by Professor Tracy George & Professor Juliana Schwaab Dr Johannes Lübke Professor Juliana Schwaab Professor Frank Siebenhaar Dr Iván Álvarez-Twose

08:30–09:30

SESSION 8: Prognostication and efficacy of novel TKIs in SM

• Development of MARS-R • Efficacy of recently approved and novel TKIs in SM clinicalpractice • Real-world data of avapritinib-treated patients with ISM • Diagnosis, prognostication and therapy of WDSM

Chaired by Professor Tracy George & Professor Juliana Schwaab Dr Johannes Lübke Professor Juliana Schwaab Professor Frank Siebenhaar Dr Iván Álvarez-Twose

08:30–09:30

SESSION 8: Prognostication and efficacy of novel TKIs in SM

• Development of MARS-R • Efficacy of recently approved and novel TKIs in SM clinicalpractice • Real-world data of avapritinib-treated patients with ISM • Diagnosis, prognostication and therapy of WDSM

Chaired by Professor Tracy George & Professor Juliana Schwaab Dr Johannes Lübke Professor Juliana Schwaab Professor Frank Siebenhaar Dr Iván Álvarez-Twose

09:30–10:00

Morning coffee break

09:30–10:00

Morning coffee break

09:30–10:00

Morning coffee break

10:00–12:00

SESSION 9: Invited presentations and late-breaking abstracts

Chaired by Dr Deepti Radia & Professor Jason Gotlib

10:00–12:00

SESSION 9: Invited presentations and late-breaking abstracts

Chaired by Dr Deepti Radia & Professor Jason Gotlib

10:00–12:00

SESSION 9: Invited presentations and late-breaking abstracts

Chaired by Dr Deepti Radia & Professor Jason Gotlib

12:00–13:00

Lunch break and poster sessions

12:00–13:00

Lunch break and poster sessions

12:00–13:00

Lunch break and poster sessions

13:00–14:15

SESSION 10: Updates in management of advanced and non-advanced systemic mastocytosis – looking forwards

• Non-advanced SM landscape: TKIs • Non-advanced SM landscape: Non-TKIs • Mutational landscape changing the paradigm for treatment • Advanced SM landscape and complete remission and cure: The new goal in patients with advanced SM: Status 2025 • Role of allogeneic BMT

Chaired by Professor Frank Siebenhaar & Professor Peter Valent Professor Cem Akin Professor Vito Sabato Professor Andreas Reiter Professor Jason Gotlib Dr Deepti Radia

13:00–14:15

SESSION 10: Updates in management of advanced and non-advanced systemic mastocytosis – looking forwards

• Non-advanced SM landscape: TKIs • Non-advanced SM landscape: Non-TKIs • Mutational landscape changing the paradigm for treatment • Advanced SM landscape and complete remission and cure: The new goal in patients with advanced SM: Status 2025 • Role of allogeneic BMT

Chaired by Professor Frank Siebenhaar & Professor Peter Valent Professor Cem Akin Professor Vito Sabato Professor Andreas Reiter Professor Jason Gotlib Dr Deepti Radia

13:00–14:15

SESSION 10: Updates in management of advanced and non-advanced systemic mastocytosis – looking forwards

• Non-advanced SM landscape: TKIs • Non-advanced SM landscape: Non-TKIs • Mutational landscape changing the paradigm for treatment • Advanced SM landscape and complete remission and cure: The new goal in patients with advanced SM: Status 2025 • Role of allogeneic BMT

Chaired by Professor Frank Siebenhaar & Professor Peter Valent Professor Cem Akin Professor Vito Sabato Professor Andreas Reiter Professor Jason Gotlib Dr Deepti Radia

14:15–14:30

Summary of Day 3 and closing remarks

Professor Peter Valent Professor Massimo Triggiani Dr Deepti Radia Dr Clive Grattan

14:15–14:30

Summary of Day 3 and closing remarks

Professor Peter Valent Professor Massimo Triggiani Dr Deepti Radia Dr Clive Grattan

14:15–14:30

Summary of Day 3 and closing remarks

Professor Peter Valent Professor Massimo Triggiani Dr Deepti Radia Dr Clive Grattan